Welcome to our dedicated page for Hercules Capital SEC filings (Ticker: HTGC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hercules Capital, Inc. filings document the regulatory reporting of a specialty finance company that provides senior secured venture growth loans to technology and life sciences businesses. Its Form 8-K filings cover earnings releases, operating and financial condition updates, cash distribution declarations, executive leadership changes and related exhibits.
Proxy materials describe annual meeting matters, board governance, executive compensation and equity-award disclosures. The company’s filings also identify its NYSE-listed common stock under HTGC and its 6.25% Notes due 2033 under HCXY, tying capital-structure disclosures to both equity and debt securities.
Hercules Capital, Inc. (HCXY) reported that President Seth H. Meyer had 5 shares of common stock disposed of on September 9, 2026 in a transaction reported as shares delivered or withheld for payment of tax liability related to vesting of restricted stock. Following this tax-withholding event, he directly holds 435,600 shares of Hercules Capital common stock.
Hercules Capital, Inc. reported strong second‑quarter 2026 results, with record total investment income of $149.1 million, up 8.5% year‑over‑year, and net investment income (NII) of $92.9 million, up 4.7%. First‑half 2026 total investment income reached $290.7 million and NII $181.0 million, increases of 13.1% and 8.9% year‑over‑year, supported by record $2.74 billion in new debt and equity commitments and $1.35 billion in fundings.
NII of $0.50 per share in Q2 2026 provided 125% coverage of the base cash distribution. The Board declared a total cash distribution of $0.47 per share for the quarter, comprising a $0.40 base and $0.07 supplemental amount, with an August 11, 2026 record date and August 18, 2026 payment date. Net asset value was $12.15 per share on $2.27 billion of net assets, up 2.1% from Q1 2026, aided by $29.6 million of net unrealized appreciation.
The company ended the quarter with $652.9 million of available liquidity and a largely floating‑rate loan book, while maintaining a GAAP leverage ratio of 103.9% and loans on non‑accrual representing 0.3% of investments at cost.
HCXY presents a detailed portfolio of debt, equity, warrant and fund investments across technology, healthcare, consumer, defense, sustainable energy and other sectors. Most credit positions are senior secured loans tied to Prime or SOFR benchmarks with stated spreads, floor rates, and in many cases payment‑in‑kind interest and exit fees.
The portfolio includes numerous positions in application and system software, drug discovery and development, healthcare services, space technologies and sustainable and renewable technology, along with convertible debt in select issuers. The company also holds preferred and common equity stakes, warrants, interests in external investment funds, cash in the GS Financial Square Government Fund and a Great British Pound foreign‑currency contract with Goldman Sachs Bank USA, with disclosures spanning as of June 30, 2026 and December 31, 2025.
Hercules Capital, Inc. completed a registered public offering of $325,000,000 aggregate principal amount of its 6.300% Notes due 2031, issued under an Eleventh Supplemental Indenture to its existing base indenture. The Notes mature on July 24, 2031 and bear interest at 6.300% per year, paid semiannually on January 24 and July 24, beginning January 24, 2027.
The Notes are unsecured senior obligations, ranking senior to expressly subordinated debt, pari passu with other unsubordinated liabilities, and effectively or structurally subordinated to secured debt and subsidiary obligations. They are redeemable at the company’s option at par plus any applicable make whole premium. Hercules Capital expects to use net proceeds to repay outstanding unsecured and/or secured indebtedness under its financing arrangements, fund investments consistent with its investment objectives, and for other general corporate purposes. The offering was conducted from the company’s Form N-2 shelf registration, with Goldman Sachs & Co. LLC and SMBC Nikko Securities America, Inc. acting as representatives of the underwriters.
Hercules Capital provides preliminary, unaudited estimates for the quarter ended June 30, 2026. Net asset value per share is expected to range from $12.10 to $12.20, up $0.20 to $0.30, or 1.7% to 2.5%, from $11.90 on March 31, 2026. Preliminary net realized gains are approximately $7.7 million and net investment income is estimated at $0.49 to $0.51 per share.
Preliminary gross new investment commitments are about $0.9 billion with fundings of $0.6 billion. Investments on non-accrual status comprised less than 0.5% of the total investment portfolio at cost as of June 30, 2026, compared with 0.2% at March 31, 2026. Total investments at fair value are estimated at $4.5 to $4.6 billion. These figures remain subject to completion of financial closing and review procedures and have not been audited or reviewed by the independent registered public accounting firm.
Hercules Capital, Inc. Chief Operating Officer Christian Follmann reported compensation-related equity activity in Common Stock. On July 9, 2026, a total of 2,798 shares were surrendered in two tax-withholding dispositions at $15.69 per share to cover taxes on the vesting of restricted stock, rather than being sold in the open market. Following these transactions, Follmann holds 144,539 shares directly and 350 shares indirectly through his spouse.
Hercules Capital, Inc. president Seth H. Meyer reported two Form 4 transactions involving common stock on July 9, 2026. A total of 6,469 shares were disposed of at $15.69 per share as tax-withholding dispositions to cover taxes on the vesting of restricted stock. These were not open-market sales. After the transactions, Meyer continued to hold over 435,000 shares of Hercules Capital common stock directly.
Hercules Capital, Inc. Chief Executive Officer Scott Bluestein reported two Form 4 transactions involving the company’s common stock on July 9, 2026. In both cases, shares were disposed of under code F, which reflects shares withheld to cover tax obligations rather than open-market sales.
The transactions relate to the vesting of restricted stock, with an aggregate of 20,393 shares of common stock withheld at a reference price of $15.69 per share to pay applicable taxes. After these tax-withholding dispositions, Bluestein continues to hold a direct ownership position of more than 2.4 million shares of Hercules Capital common stock.
Hercules Capital, Inc. officer Kiersten Zaza Botelho, Chief Legal Officer & CCO, reported two tax-withholding dispositions of common stock on July 9, 2026. A total of 1,974 shares were withheld at $15.69 per share to cover taxes on vesting restricted stock, with substantial share ownership reported remaining afterward.
BADAVAS ROBERT P reported acquisition or exercise transactions in this Form 4 filing.
Hercules Capital director Robert P. Badavas reported updated holdings and a new share grant. He received 3,873 shares of common stock as a restricted stock award at $15.49 per share, issued automatically upon his re-election to the board under the 2026 Non-Employee Director Plan. Following this grant, he directly holds 8,943 shares, and a trust identified as the Robert P. Badavas Trust of 2007 holds 122,073 shares indirectly. The restricted stock is subject to forfeiture, with one-third vesting on each anniversary of the grant over three years.